Nrgene (NRGN) Stock Statistics & Valuation Metrics

Nrgene has a market cap or net worth of 35.10M. The enterprise value is 9.79M.

Nrgene has 13,091,577 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nrgene’s return on equity (ROE) is -0.85 and return on invested capital (ROIC) is -76.69%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Nrgene had revenue of 1.29M and earned -3.36M in profits. Earnings per share was -0.28.

In the last 12 months, operating cash flow was -3.56M and capital expenditures -1.63M, giving a free cash flow of -5.19M billion.

Nrgene pays an annual dividend of ―, resulting in a dividend yield of ―

Nrgene upcoming earnings date is Sep 2, 2025, TBA (Not Confirmed).

Nrgene as a current ratio of 1.11, with Debt / Equity ratio of 7.27%

In the past 12 months, Nrgene has paid -8.00K in taxes.

Nrgene EV to EBITDA ratio is -2.72, with an EV/FCF ratio of -1.41.

Nrgene has 1.37M in cash and marketable securities with $288.00K in debt, giving a net cash position of -1.08M billion.

Gross margin is 45.12%, with operating margin of -256.82%, and net profit margin of -260.39%.

The average price target for Nrgene is ―, which is 11.43% higher than the current price. The consensus rating is ―